Multi-year partnership to advance the use of next-generation sequencing for decentralized oncology testing and to bring improved insights to patients with breast cancer globally SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) today announced a multi-year partnership with Agendia N.V., a world leader in precision oncology for breast cancer, to co-develop in vitro diagnostic (IVD) tests for […]
Collaboration will transform new insights into drug discovery and therapy development through large-scale genomics SAN DIEGO — Illumina, Inc. (NASDAQ: ILMN) and Nashville Biosciences, LLC, a wholly-owned subsidiary of Vanderbilt University Medical Center (VUMC), today announced a multi-year agreement to accelerate medicines development through large-scale genomics and the establishment of a preeminent clinico-genomic resource. Using […]
BOULDER, Colo. — SomaLogic (NASDAQ: SLGC), a leader in data-driven proteomics technology, today announced that Adam Taich has joined the company as the Chief Business Officer. In this newly created role, Adam will have broad responsibility across SomaLogic’s rapidly growing business to drive the company’s strategic and business development goals. He will also serve as […]
SAN DIEGO — Illumina Inc. (NASDAQ: ILMN) today announced a partnership with Boehringer Ingelheim to develop companion diagnostics (CDx) for several programs in Boehringer Ingelheim’s oncology pipeline. The partnership aims to accelerate the development of therapy selection and precision medicines for patients with advanced cancer. The partnership spans current and future CDx programs, with plans […]
Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has adopted the Onyx® Genome Engineering Platform in its foundries. BOULDER, CO. — Inscripta®, the Digital Genome Engineering Company, today announced that Ginkgo Bioworks (NYSE: DNA), the leading horizontal platform for cell programming, has adopted the Onyx® Genome Engineering Platform in its foundries. Ginkgo’s investment is part […]
GUILFORD, Conn. — Quantum-Si Incorporated (Nasdaq: QSI) (“Quantum-Si,” or the “Company”), a life sciences tools company commercializing a single molecule protein sequencing platform, today announced that management will discuss the following business updates at the 40th Annual J.P. Morgan Healthcare Conference. Commercial update Quantum-Si has established list prices for its end-to-end protein sequencing platform as follows: $70,000 […]
Multiple innovative partnerships with healthcare companies, research institutions, and multiomic developers, along with new groundbreaking technologies, including a new SBS chemistry and long-read capabilities, position Illumina to accelerate genomic adoption and improve human health globally SAN DIEGO — Illumina, Inc. (NASDAQ:ILMN) Chief Executive Officer, Francis deSouza, discussed today the company’s strong growth trajectory, including 2021 […]
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH LEXOGEN’S EXPERTISE IN RNA LIBRARY PREPARATION KITS TO EMPOWER SPECIALIZED WORKFLOWS FOR CUSTOMERS. LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with Lexogen to […]
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE NEBNEXT DNA AND RNA LIBRARY PREP KITS TO EMPOWER HIGH-QUALITY, ESTABLISHED WORKFLOWS FOR CUSTOMERS LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with […]
THIS PARTNERSHIP INTEGRATES G4’S ACCURACY, SPEED, FLEXIBILITY AND POWER WITH THE TWIST TARGET ENRICHMENT SOLUTIONS TO EMPOWER FIXED AND CUSTOM TARGETED SEQUENCING PANELS FOR CUSTOMERS. LA JOLLA, Calif. — Singular Genomics Systems, Inc. (Nasdaq: OMIC), a company leveraging novel next-generation sequencing (NGS) and multiomics technologies to empower researchers and clinicians, today announced a partnership with […]
Pay Invoice
Latest Blogs
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
-
Carterra Introduces Faster SPR
March 27, 2026 7:26 pm
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
